Effect of intracellular iron loading on lipid peroxidation of brain slices

Free Radical Biology and Medicine

Volumn 21, Issue 6, 1996, Pages 763-769

  Oubidar, Mohamed ^a   Boquillon, Micheline ^a   Marie, Christine ^a   Bouvier, Christine ^a   Beley, Alain ^a   Bralet, Jean ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

8 Hydroxyquinoline; Brain homogenates; Brain slices; Free radicals; Hydroxyl radicals; Iron complexes; Lipid peroxidation

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; 8 QUINOLINOL; CITRIC ACID; FERRIC ION; HYDROGEN PEROXIDE; IRON COMPLEX; SALICYLIC ACID DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; BRAIN METABOLISM; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG POTENTIATION; IRON METABOLISM; IRON TRANSPORT; LIPID PEROXIDATION; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029909829     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00173-6     Document Type: Article

References (34)

1. 1. Kogure, K.; Arai, H.; Abe, K.; Nakano, M. Free radical damage of the brain following ischemia. In: Kogure, K.; Hossmann, K. A.; Siesjö, B. K.; Welsh, F. A. eds. Progress in brain research. vol. 63. Amsterdam: Elsevier; 1985:237-259.
2. 2. Braughler, J. M.; Hall, E. D. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6:289-301; 1989.
3. 3. Bromont, C.; Marie, C.; Bralet, J. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke 20:918-924; 1989.
4. 4. Bralet, J.; Bouvier, C.; Schreiber, L.; Boquillon, M. Effect of acidosis on lipid peroxidation in brain slices. Brain Res. 539:175-177; 1991.
5. 5. Samokyszyn, V. M.; Thomas, C. E.; Reif, D. W.; Saito, M.; Aust, S. D. Release of iron from ferritin and its role in oxygen radical toxicities. Drug Metab. Rev. 19:283-303; 1988.
6. 6. Krause, G. S.; Joyce, K. M.; Nayini, N. R.; Zonia, C. L.; Garritano, A. M.; Hoehner, T. J.; Evans, A. T.; Indreri, R. J.; Huang, R. R.; Aust, S. D.; White, B. C. Cardiac arrest and resuscitation: Brain iron delocalizadon during reperfusion. Ann. Emerg. Med. 14:1037-1043; 1985.
7. 7. Healing, G.; Gower, J.; Fuller, B.; Green, C. Intracellular iron redistribution. An important determinant of reperfusion damage to rabbit kidneys. Biochem. Pharmacol. 39:1239-1245; 1990.
8. 8. Bralet, J.; Schreiber. L.; Bouvier, C. Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem. Pharmacol. 43:979-983; 1992.
9. 9. Rothman, R. J.; Serroni, A.; Farber, J. L. Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol. Pharmacol. 42:703-710; 1992.
10. 10. Bakkeren, D. L.; de Jeu-Jaspars, C. M. H.; Van der Heul, C.; Van Eijk, H. G. Analysis of iron-binding components in the low molecular weight fraction of rat reticulocyte cytosol. Int. J. Biochem. 17:925-930; 1985.
11. 11. Weaver, J.; Pollack, S. Low-Mr iron isolated guinea pig reticulocytes as AMP-Fe and ATP-Fe complexes. Biochem. J. 261:787-792; 1989.
12. 12. Oubidar, M.; Boquillon, M.; Marie, C.; Schreiber, L.; Bralet, J. Ischemia-induced brain iron delocalization: Effect of iron chelators. Free Radic. Biol. Med. 16:861-867; 1994.
13. 13. Kompala, S. D.; Babbs, C. F.; Blaho, K. E. Effects of deferoxamine on late deaths following CPR in rats. Ann. Emerg. Med. 15:405-407; 1986.
14. 14. Badylak, S. F.; Babbs, C. F. The effect of carbon dioxide, lidoflazine and deferoxamine upon long term survival following cardiorespiratory arrest in rats. Resuscitation 13:165-173; 1986.
15. 15. Cerchiari, E. L.; Hoel, T. M.; Safar, P.; Sclabassi, R. J. Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs. Stroke 18:869-878; 1987.
16. 16. Smith, D. H.; Gennarelli, T. A.; McIntosch, T. K. The potential of 21-aminosteroids (Lazaroids) as neuroprotective therapies in CNS injury. CNS Drugs 3:159-164; 1995.
17. 17. Ikeda, Y.; Ikeda, K.; Long, D. M. Comparative study of different iron-chelating agents in cold-induced brain edema. Neurosurgery 24:820-824; 1989.
18. 18. Kontoghiorghes, G. J.; Piga, A.; Hoffbrand, A. V. Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines. Hematol. Oncol. 4:195-204; 1986.
19. 19. Jonas, S. K.; Riley, P. A. The effect of ligands on the uptake of iron by cells in culture. Cell Biochem. Funct. 9:245-253; 1991.
20. 20. Buettner, G. R. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: Ascorbate as a test for catalytic metals. J. Biochem. Biophys. Methods 16:27-40; 1988.
21. 21. Balla, G.; Vercellotti, G. M.; Eaton, J. W.; Jacob, H. S. Iron loading of endothelial cells augments oxidant damage. J. Lab. Clin. Med. 116:546-554; 1990.
22. 22. Floyd, R. A.; Watson, J. J.; Wong, P. K. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods 10:221-235; 1984.
23. 23. Inman, R. S.; Wessling-Resnick, M. Characterization of transferrin-independent iron transport in K562 cells. J. Biol. Chem. 268:8521-8528; 1993.
24. 24. Breuer, W.; Epsztejn, S.; Millgram, P.; Cabantchik, I. Z. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am. J. Physiol. 268:C1354-C1361; 1995.
25. 25. Albert, A.; Rubbo, S. D.; Goldacre, R. J.; Balfour, B. G. Influence of chemical constitution on antibacterial activity; study of 8-hydroxyquinoline (oxine) and related compounds. Br. J. Exp. Pathol. 28:69-87; 1947.
26. 26. Braughler, J. M.; Duncan, L. A.; Chase, R. L. The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J. Biol. Chem. 261:10282-10289; 1986.
27. 27. Minotti, G.; Aust, S. D. The role of iron in oxygen radical mediated lipid peroxidation. Chem. Biol. Interact. 71:1-19; 1989.
28. 28. Minotti, G.; Aust, S. D. Redox cycling of iron and lipid peroxidation. Lipids 27:219-226; 1992.
29. 29. Arai, H.; Kogure, K.; Sugioka, K.; Nakano, M. Importance of two iron-reducing systems in lipid peroxidation of rat brain: Implications for oxygen toxicity in the central nervous system. Biochem. Int. 14:741-749; 1987.
30. 30. Jonas, S. K.; Riley, P. A. Modification of the in vitro cytotoxicity of hydrogen peroxide by iron complexes. Free Radic. Res. Commun. 17:407-419; 1992.
31. 31. Jesberger, J. A.; Richardson. J. S. Oxygen free radicals and brain dysfunction. Intern. J. Neurosci. 57:1-17; 1991.
32. 32. Gelman, B. B. Iron in CNS disease. J. Neuropathol. Exp. Neurol. 54:477-486; 1995.
33. 33. Hall, E. D.; Braughler, J. M. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6:303-313; 1989.
34. 34. Gerlach, M.; Riederer, P.; Youdim, M. B. H. Neuroprotective therapeutic strategies. Comparison of experimental and clinical results. Biochem. Pharmacol. 50:1-16; 1995.